Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

• Conditions: Pharmacogenomic

• Registration Number: NCT03322189
• Lead Sponsor: Data Collection Analysis Business Management

Brief Summary

Current providers' standard operating procedures on pharmacogenomic testing patients

Detailed Description

The general design of this study is collecting data and reviewing Principal Investigators' Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific SOP.

Study Timeline

• Study Start: 2017-03-22
• Study First Submitted: 2017-10-24
• Study First Submitted QC: 2017-10-25
• Study First Posted: 2017-10-26
• Status Verified: 2019-01
• Last Update Submitted: 2019-01-22
• Last Update Posted: 2019-01-23
• Primary Completion: 2020-03-22
• Study Completion: 2020-04-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Must be a Medical Practitioner

  • Medical Doctor (MD)
  • Doctor of Osteopathic (DO)
  • Physician Assistant (PA)
  • Advanced Practice Registered Nurse (APRN)
  • Nurse Practioner (NP)

• Must have a current standard operating procedure that includes obtaining/reviewing medical history.

Exclusion Criteria

• Government-funded insurance data cannot be included in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Provider Structures and Processes	36 months	Plan of Care Changes due to Pharmacogenomic testing. Provider based observational survey system on the health and well-being of patients and populations

Trial Locations

Locations (1)

DCABM; 🇺🇸 Land O' Lakes, Florida, United States